Co-occurring Mutations in Different Genes Can Fuel Oncogenic Signaling and Serve as Metastatic Tumor Markers
Preprint in bioRxiv (January 2024)
The most recent citing publications are shown below. View all 43 publications that cite this research output on Dimensions.
SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities
Article in Cellular and Molecular Life Sciences (December 2023)
Progress in the study of FOXO3a interacting with microRNA to regulate tumourigenesis development
Article in Frontiers in Oncology (October 2023)